To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.

HB 1285 To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug

US Congress 113th Congress

To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
HB-1285


About HB-1285

Amends the Controlled Substances Act to remove dihydrocodeinone (hydrocodone) from classification as a schedule III controlled substance. Directs the Attorney General to immediately allow manufacturers and distributors to store hydrocodone compound products in accordance with the physical security requirements for schedule III, IV, and V controlled substances for three years beginning on the date enactment of this Act. Requires the Comptroller General to submit a report on the reclassification of hydrocodone products under this Act, including:

  • (1) an assessment of the degree to which the reclassification of such products under this Act impacts the ability of patients with legitimate medical needs, particularly those in rural areas and nursing home facilities, to access adequate pain management; and
  • (2) recommendations necessary to address any issues relating to patient access to adequate pain management.

  

Bill Texts

Introduced 03/26/2013

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Sponsors (55)

Sponsors by party

     

Bill Sponsors

History

Referred To The Subcommittee On Crime, Terrorism, Homeland Security, And Investigations.

04/15/2013

Referred To The Subcommittee On Health.

03/22/2013

Referred To The Committee On Energy And Commerce, And In Addition To The Committee On The Judiciary, For A Period To Be Subsequently Determined By The Speaker, In Each Case For Consideration Of Such Provisions As Fall Within The Jurisdiction Of The Committee Concerned.

03/20/2013

Referred To House Energy And Commerce

03/20/2013

Referred To House Judiciary

03/20/2013